vs

Side-by-side financial comparison of Amalgamated Financial Corp. (AMAL) and Schrodinger, Inc. (SDGR). Click either name above to swap in a different company.

Schrodinger, Inc. is the larger business by last-quarter revenue ($87.2M vs $85.2M, roughly 1.0× Amalgamated Financial Corp.). On growth, Amalgamated Financial Corp. posted the faster year-over-year revenue change (9.4% vs -1.2%). Amalgamated Financial Corp. produced more free cash flow last quarter ($134.4M vs $-16.1M). Over the past eight quarters, Schrodinger, Inc.'s revenue compounded faster (54.4% CAGR vs 4.3%).

CI Financial is a Canadian investment management company based in Toronto, Ontario. It offers investment management and wealth management services targeted to high net worth retail investors, as well as brokerage and trading services to portfolio managers and institutional investors.

Schrodinger, Inc. is a leading provider of advanced computational chemistry and physics software platforms, along with related consulting services, focused on accelerating drug discovery and novel materials development. Its solutions are adopted by biopharmaceutical companies, chemical manufacturers, academic research institutions and government entities across North America, Europe and Asia Pacific to cut R&D costs and shorten innovation cycles.

AMAL vs SDGR — Head-to-Head

Bigger by revenue
SDGR
SDGR
1.0× larger
SDGR
$87.2M
$85.2M
AMAL
Growing faster (revenue YoY)
AMAL
AMAL
+10.6% gap
AMAL
9.4%
-1.2%
SDGR
More free cash flow
AMAL
AMAL
$150.5M more FCF
AMAL
$134.4M
$-16.1M
SDGR
Faster 2-yr revenue CAGR
SDGR
SDGR
Annualised
SDGR
54.4%
4.3%
AMAL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AMAL
AMAL
SDGR
SDGR
Revenue
$85.2M
$87.2M
Net Profit
$32.5M
Gross Margin
65.7%
Operating Margin
39.0%
-19.7%
Net Margin
37.3%
Revenue YoY
9.4%
-1.2%
Net Profit YoY
180.8%
EPS (diluted)
$0.88
$0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMAL
AMAL
SDGR
SDGR
Q4 25
$85.2M
$87.2M
Q3 25
$85.6M
$54.3M
Q2 25
$80.9M
$54.8M
Q1 25
$77.0M
$59.6M
Q4 24
$77.9M
$88.3M
Q3 24
$81.0M
$35.3M
Q2 24
$78.5M
$47.3M
Q1 24
$78.3M
$36.6M
Net Profit
AMAL
AMAL
SDGR
SDGR
Q4 25
$32.5M
Q3 25
$26.8M
$-32.8M
Q2 25
$26.0M
$-43.2M
Q1 25
$25.0M
$-59.8M
Q4 24
$-40.2M
Q3 24
$27.9M
$-38.1M
Q2 24
$26.8M
$-54.0M
Q1 24
$27.2M
$-54.7M
Gross Margin
AMAL
AMAL
SDGR
SDGR
Q4 25
65.7%
Q3 25
51.6%
Q2 25
47.8%
Q1 25
52.3%
Q4 24
72.6%
Q3 24
50.2%
Q2 24
66.2%
Q1 24
51.6%
Operating Margin
AMAL
AMAL
SDGR
SDGR
Q4 25
39.0%
-19.7%
Q3 25
42.9%
-84.6%
Q2 25
43.8%
-96.6%
Q1 25
45.1%
-85.5%
Q4 24
42.4%
-23.5%
Q3 24
47.2%
-193.9%
Q2 24
45.6%
-111.4%
Q1 24
49.2%
-184.3%
Net Margin
AMAL
AMAL
SDGR
SDGR
Q4 25
37.3%
Q3 25
31.3%
-60.4%
Q2 25
32.1%
-78.8%
Q1 25
32.5%
-100.4%
Q4 24
-45.5%
Q3 24
34.5%
-108.1%
Q2 24
34.1%
-114.2%
Q1 24
34.8%
-149.5%
EPS (diluted)
AMAL
AMAL
SDGR
SDGR
Q4 25
$0.88
$0.45
Q3 25
$0.88
$-0.45
Q2 25
$0.84
$-0.59
Q1 25
$0.81
$-0.82
Q4 24
$0.78
$-0.55
Q3 24
$0.90
$-0.52
Q2 24
$0.87
$-0.74
Q1 24
$0.89
$-0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMAL
AMAL
SDGR
SDGR
Cash + ST InvestmentsLiquidity on hand
$291.2M
$395.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$794.5M
$364.1M
Total Assets
$8.9B
$726.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMAL
AMAL
SDGR
SDGR
Q4 25
$291.2M
$395.5M
Q3 25
$115.5M
$391.2M
Q2 25
$171.1M
$450.2M
Q1 25
$65.7M
$500.3M
Q4 24
$60.7M
$352.1M
Q3 24
$149.2M
$388.7M
Q2 24
$58.0M
$377.3M
Q1 24
$155.2M
$431.1M
Stockholders' Equity
AMAL
AMAL
SDGR
SDGR
Q4 25
$794.5M
$364.1M
Q3 25
$775.6M
$321.4M
Q2 25
$754.0M
$342.9M
Q1 25
$736.0M
$373.5M
Q4 24
$707.7M
$421.4M
Q3 24
$698.2M
$449.4M
Q2 24
$646.0M
$474.0M
Q1 24
$616.8M
$513.7M
Total Assets
AMAL
AMAL
SDGR
SDGR
Q4 25
$8.9B
$726.2M
Q3 25
$8.7B
$653.7M
Q2 25
$8.6B
$688.2M
Q1 25
$8.3B
$743.0M
Q4 24
$8.3B
$823.2M
Q3 24
$8.4B
$669.3M
Q2 24
$8.3B
$688.4M
Q1 24
$8.1B
$737.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMAL
AMAL
SDGR
SDGR
Operating Cash FlowLast quarter
$135.8M
$-16.1M
Free Cash FlowOCF − Capex
$134.4M
$-16.1M
FCF MarginFCF / Revenue
157.8%
-18.5%
Capex IntensityCapex / Revenue
1.6%
0.0%
Cash ConversionOCF / Net Profit
-0.50×
TTM Free Cash FlowTrailing 4 quarters
$229.4M
$12.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMAL
AMAL
SDGR
SDGR
Q4 25
$135.8M
$-16.1M
Q3 25
$39.5M
$-61.9M
Q2 25
$24.9M
$-52.2M
Q1 25
$34.2M
$144.1M
Q4 24
$124.1M
$-31.1M
Q3 24
$35.8M
$-33.3M
Q2 24
$28.0M
$-53.7M
Q1 24
$31.3M
$-39.3M
Free Cash Flow
AMAL
AMAL
SDGR
SDGR
Q4 25
$134.4M
$-16.1M
Q3 25
$38.3M
$-62.4M
Q2 25
$24.2M
$-52.5M
Q1 25
$32.5M
$143.5M
Q4 24
$122.3M
$-32.0M
Q3 24
$35.2M
$-34.6M
Q2 24
$27.8M
$-54.7M
Q1 24
$31.1M
$-43.4M
FCF Margin
AMAL
AMAL
SDGR
SDGR
Q4 25
157.8%
-18.5%
Q3 25
44.7%
-114.8%
Q2 25
29.9%
-95.9%
Q1 25
42.2%
240.9%
Q4 24
157.0%
-36.2%
Q3 24
43.4%
-98.0%
Q2 24
35.4%
-115.6%
Q1 24
39.7%
-118.5%
Capex Intensity
AMAL
AMAL
SDGR
SDGR
Q4 25
1.6%
0.0%
Q3 25
1.4%
0.9%
Q2 25
0.9%
0.6%
Q1 25
2.3%
1.0%
Q4 24
2.3%
1.0%
Q3 24
0.7%
3.8%
Q2 24
0.3%
2.1%
Q1 24
0.3%
11.2%
Cash Conversion
AMAL
AMAL
SDGR
SDGR
Q4 25
-0.50×
Q3 25
1.47×
Q2 25
0.96×
Q1 25
1.37×
Q4 24
Q3 24
1.28×
Q2 24
1.05×
Q1 24
1.15×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMAL
AMAL

Segment breakdown not available.

SDGR
SDGR

On Premise Software$44.4M51%
Drug Discovery Services$17.6M20%
Hosted Software$11.5M13%
Maintenance$6.9M8%
Professional Services$3.8M4%
July2024Agreement With Bill Melinda Gates Foundation$2.7M3%

Related Comparisons